Form 4: LeMaitre Vascular Exec Reports Stock Transactions

LeMaitre Vascular's Senior VP of Operations, Trent G. Kamke, reported the acquisition of 10 common shares from dividend equivalent rights and the disposition of 53 shares for tax withholding related to a restricted stock unit vesting.

Summary

• Trent G. Kamke, Senior V.P., Operations at LeMaitre Vascular, Inc., reported transactions involving the company's common stock.
• On December 2, 2025, Kamke acquired 10 shares of common stock at a price of $0, resulting from the release of dividend equivalent rights.
• Concurrently, 53 shares of common stock were disposed of at a price of $83.68 per share to satisfy tax withholding obligations related to the vesting of restricted stock units awarded on December 2, 2020.
• Following these transactions, Kamke directly beneficially owns 3,710 shares of common stock.
• The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating they were pre-arranged.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to executive compensation (vesting of equity awards and associated tax withholding). These are expected and do not indicate any significant positive or negative sentiment regarding the company's performance or outlook.

Positives

• Acquisition of 10 common shares through the release of dividend equivalent rights, increasing direct ownership.
• The transactions are part of a pre-arranged Rule 10b5-1(c) plan, indicating planned and compliant insider activity.

Negatives

• Disposition of 53 shares to cover tax withholding obligations, which reduces direct share ownership.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's future performance or strategy.

Management Comments

• "The undersigned hereby constitutes and appoints Laurie Churchill, John Pitfield, Bernard Stanford, and Secil Kantarci ONeil, signing singly, and with full power of substitution, the undersigned's true and lawful attorney-in-fact..."
• "The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigneds responsibilities to comply with Section 16 or Regulation 13D-G of the Securities Exchange Act of 1934, as amended."

Industry Context

This insider transaction report is a routine disclosure and does not provide specific insights into broader industry trends or competitive landscape. It reflects standard compensation practices within the medical device sector, where restricted stock units and dividend equivalent rights are common forms of executive remuneration.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) and dividend equivalent rights (DERs) as part of executive compensation is a common practice across various industries, including the medical device sector, aligning executive incentives with shareholder value.
• The disposition of shares to cover tax withholding obligations upon RSU vesting is a standard and expected procedure, consistent with practices observed in companies like Medtronic (MDT) or Boston Scientific (BSX) when their executives' equity awards vest.
• The filing under a Rule 10b5-1(c) plan demonstrates adherence to SEC regulations for pre-planned insider transactions, a best practice for corporate governance to avoid accusations of trading on material non-public information.

Corporate Governance

Stakeholder Impact

• Shareholders: Minimal direct impact. The transactions are routine and pre-planned, reflecting standard executive compensation practices. The slight reduction in direct ownership due to tax withholding is a common occurrence.
• Employees: No direct impact.
• Management: The Power of Attorney streamlines SEC filing processes for the Senior V.P., Operations, reducing administrative burden.

Next Steps

• Continued compliance with Section 16 reporting requirements for future transactions by Trent G. Kamke.

Key Dates

Keywords

LeMaitre Vascular, LMAT, Trent G. Kamke, Insider Trading, Form 4, Stock Transaction, Restricted Stock Units, Dividend Equivalent Rights, Tax Withholding, Corporate Governance, SEC Filing